Table 3.
Medication at Discharge
| Overall (N = 13,647) | Cancer (n = 1,368) | No Cancer (n = 12,279) | p Value | |
|---|---|---|---|---|
| Aspirin | 13,219 (96.9) | 1,318 (96.3) | 11,901 (97.0) | 0.217 |
| Clopidogrel | 7,851 (57.6) | 908 (66.4) | 6,943 (56.6) | <0.001 |
| Potent P2Y12 (prasugrel or ticagrelor) | 5,517 (40.5) | 419 (30.6) | 5,098 (41.6) | <0.001 |
| Any DAPT | 12,968 (95.2) | 1,284 (93.9) | 11,684 (95.3) | 0.024 |
| Oral anticoagulation | 1,116 (8.2) | 156 (11.4) | 960 (7.9) | <0.001 |
| Direct oral anticoagulants | 318 (3.4) | 48 (4.8) | 270 (3.2) | 0.012 |
| Any DAPT and OAC/DOAC | 1,149 (8.6) | 163 (12.3) | 986 (8.2) | <0.001 |
| Statin | 12,232 (90.3) | 1,170 (85.8) | 11,062 (90.8) | <0.001 |
Values are n (%).
DAPT = dual antiplatelet therapy; DOAC = direct oral anticoagulant; OAC = oral anticoagulant.